Clinical implications of alpha 1 adrenergic blockade and angiotensin converting enzyme inhibition 'cross talk' in heart failure in Nigerians.
Ajayi
A A
AA
Sofowora
G
G
Balogun
M O
MO
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011224:Prazosin / Q000627:therapeutic use*; D016037:Single-Blind Method
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D011224:Prazosin